Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology.
about
Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis useNeurological soft signs in schizophrenia: a meta-analysis.Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study.The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches.Cannabis use and cognition in schizophrenia.Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis useCannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.Anhedonia and substance dependence: clinical correlates and treatment options.Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial.The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.Need for new hypotheses
P2860
Q33901507-0106BFE3-A0C9-4CAE-8AC5-BC1B0FE812ABQ34235412-EA4B3F86-4C25-4913-BAD2-4306F708DCA0Q34424644-E9177215-EB91-4A59-88EE-09023748373BQ34531537-5C9800F2-5AB5-4B65-B34D-5534201DFBA5Q36354947-9BF4D240-1C11-4E52-91CF-6FFC42A92C4BQ36364218-9D8F3647-31ED-4F84-B990-276CDB26E822Q37643444-F2FD8914-46B1-4D38-AD99-78B22FBEB167Q37705759-B50E133B-742F-4612-A3C6-C96A3F679488Q38039423-201E55CD-4D2E-4002-8DBE-CD915A94236CQ40689652-A1B749AE-55E8-4B69-9437-88A76964948FQ42728896-9FA956EC-A4C8-451B-9F1C-4E876157CFF8Q44530576-CDB95105-55F6-42DA-A025-CF1ED06DC9DEQ46661186-CD1A85D4-1BD5-4151-A342-45145CC15227Q47439536-643EB942-2177-4414-B25E-E0C1B5445E70Q52625218-3ACF048A-96CD-4141-83A3-289DE40AFD2CQ58088808-B6EB18FD-FD48-472C-A242-50F817BD61D2
P2860
Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cannabis and neurological soft ...... influence on psychopathology.
@en
Cannabis and neurological soft ...... influence on psychopathology.
@nl
type
label
Cannabis and neurological soft ...... influence on psychopathology.
@en
Cannabis and neurological soft ...... influence on psychopathology.
@nl
prefLabel
Cannabis and neurological soft ...... influence on psychopathology.
@en
Cannabis and neurological soft ...... influence on psychopathology.
@nl
P2093
P356
P1433
P1476
Cannabis and neurological soft ...... influence on psychopathology.
@en
P2093
P Pancheri
S Gherardelli
P304
P356
10.1159/000067064
P407
P577
2002-09-01T00:00:00Z